His main research concerns Environmental health, Vaccination, Cost-effectiveness analysis, Global health and Incidence. His studies in Environmental health integrate themes in fields like Immunology and Population health. His research in Population health intersects with topics in Millennium Development Goals and Malaria.
The study incorporates disciplines such as Disease burden, Cervical cancer and Pediatrics in addition to Vaccination. Raymond Hutubessy interconnects Developing country, Gynecology, Vaccine efficacy and Gross domestic product in the investigation of issues within Cervical cancer. Raymond Hutubessy combines subjects such as High mortality, Case fatality rate and Malnutrition with his study of Global health.
Raymond Hutubessy mainly focuses on Vaccination, Environmental health, Developing country, Health economics and Cost-effectiveness analysis. His Vaccination research includes elements of Cervical cancer and HPV vaccines. His Cervical cancer research is multidisciplinary, relying on both Gynecology and Incidence.
His study focuses on the intersection of Environmental health and fields such as Cholera with connections in the field of Health education. Much of his study explores Developing country relationship to Health policy. His Health economics research incorporates themes from Health services research, Actuarial science, Public economics and Health administration.
Raymond Hutubessy mainly investigates Cervical cancer, Environmental health, Vaccination, Hpv vaccination and Incidence. When carried out as part of a general Cervical cancer research project, his work on Cervical screening is frequently linked to work in High coverage, therefore connecting diverse disciplines of study. Raymond Hutubessy has researched Cervical screening in several fields, including Developing country and Confidence interval.
His Environmental health study incorporates themes from Health care and Influenza vaccine. As a part of the same scientific family, he mostly works in the field of Health care, focusing on Content validity and, on occasion, Health economics. His Global health research extends to Vaccination, which is thematically connected.
His primary areas of investigation include Cervical cancer, Incidence, Vaccination, Cervical screening and Mortality rate. He frequently studies issues relating to Young adult and Cervical cancer. His Young adult research spans across into fields like China, Rural area and Budget constraint.
His studies deal with areas such as Developing country, Hpv vaccination and HPV infection as well as Vaccination. His Mortality rate study combines topics in areas such as Cancer, Pediatrics, Disease Eradication and Action.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: A global and regional analysis on reduction of cardiovascular-disease risk
Christopher J L Murray;Jeremy A Lauer;Raymond C W Hutubessy;Louis Niessen.
The Lancet (2003)
Generalized cost-effectiveness analysis for national-level priority-setting in the health sector
Raymond Hutubessy;Dan Chisholm;Tessa Tan-Torres Edejer.
Cost Effectiveness and Resource Allocation (2003)
Cost-effectiveness thresholds: pros and cons
Melanie Y. Bertram;Jeremy A. Lauer;Kees De Joncheere;Tessa Edejer.
Bulletin of The World Health Organization (2016)
Programme costs in the economic evaluation of health interventions.
Benjamin Johns;Rob Baltussen;Raymond Hutubessy.
(2003)
Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
Marc Brisson;Marc Brisson;Jane J. Kim;Karen Canfell;Karen Canfell;Karen Canfell;Mélanie Drolet.
The Lancet (2020)
Achieving the millennium development goals for health: Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries
Tessa Tan Torres Edejer;Moses Aikins;Robert Black;Lara Wolfson.
BMJ (2005)
Cost effectiveness analysis of strategies for child health in developing countries.
Tessa Tan Torres Edejer;Moses Aikins;Robert Black;Lara Wolfson.
BMJ (2005)
Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study
Mark Jit;Mark Jit;Marc Brisson;Marc Brisson;Allison Portnoy;Raymond Hutubessy.
The Lancet Global Health (2014)
Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries
Karen Canfell;Karen Canfell;Karen Canfell;Jane J. Kim;Marc Brisson;Marc Brisson;Adam Keane;Adam Keane.
The Lancet (2020)
Health Economics of Dengue: A Systematic Literature Review and Expert Panel's Assessment
Mark E. Beatty;Philippe Beutels;Martin I. Meltzer;Donald S. Shepard.
American Journal of Tropical Medicine and Hygiene (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
London School of Hygiene & Tropical Medicine
Swiss Tropical and Public Health Institute
University of Groningen
Radboud University Nijmegen
Health Intervention and Technology Assessment Program
Johns Hopkins University
University of Washington
Swiss Tropical and Public Health Institute
UMIT Tirol - Private University for Health Sciences and Health Technology
London School of Hygiene & Tropical Medicine